ADARx Pharmaceuticals aims to raise $371.9 million in US IPO
ADARx Pharmaceuticals is seeking to raise as much as $371.9 million in its U.S. initial public offering, the company revealed in a filing on Monday.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.